Co-Diagnostics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $134.5M | $88.6M |
| FY2022 | — | $114.5M | $23.0M |
| FY2023 | — | $85.6M | $14.9M |
| FY2024 | — | $53.9M | $2.9M |
| FY2025 | — | $20.6M | $11.9M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $134.5M | $88.6M |
| FY2022 | — | $114.5M | $23.0M |
| FY2023 | — | $85.6M | $14.9M |
| FY2024 | — | $53.9M | $2.9M |
| FY2025 | — | $20.6M | $11.9M |